HBP-enhancing hepatocellular adenomas and how to discriminate them from FNH in Gd-EOB MRI

被引:20
作者
Auer, Timo Alexander [1 ,6 ]
Walter-Rittel, Thula [1 ]
Geisel, Dominik [1 ]
Schoening, Wenzel [2 ]
Schmelzle, Moritz [2 ]
Mueller, Tobias [3 ]
Sinn, Bruno [4 ]
Denecke, Timm [5 ]
Hamm, Bernd [1 ]
Fehrenbach, Uli [1 ]
机构
[1] Charite Univ Med Berlin, Campus Virchow Klinikum, Radiol Klin, Augustenburger Pl 1, D-13353 Berlin, Germany
[2] Charite Univ Med Berlin, Campus Charite Mitte Campus Virchow Klinikum, Dept Surg, Augustenburger Pl 1, D-13353 Berlin, Germany
[3] Charite Univ Med Berlin, Campus Virchow Klinikum, Med Klin Schwerpunkt Hepatol & Gastroenterol, Berlin, Germany
[4] Charite Univ Med Berlin, Inst Pathol, Charite Pl 1, D-10117 Berlin, Germany
[5] Univ Klinikum Leipzig, Dept Diagnost & Intervent Radiol, Liebigstr 20, D-04103 Leipzig, Germany
[6] Berlin Inst Hlth BIH, Anna Louisa Karsch Str 2, D-10178 Berlin, Germany
关键词
Liver; Magnetic resonance imaging; Focal nodular hyperplasia; Hepatocellular adenoma; Gd-EOB;
D O I
10.1186/s12880-021-00552-0
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
BackgroundRecent studies provide evidence that hepatocellular adenomas (HCAs) frequently take up gadoxetic acid (Gd-EOB) during the hepatobiliary phase (HBP). The purpose of our study was to investigate how to differentiate between Gd-EOB-enhancing HCAs and focal nodular hyperplasias (FNHs). We therefore retrospectively included 40 HCAs classified as HBP Gd-EOB-enhancing lesions from a sample of 100 histopathologically proven HCAs in 65 patients. These enhancing HCAs were matched retrospectively with 28 FNH lesions (standard of reference: surgical resection). Two readers (experienced abdominal radiologists blinded to clinical data) reviewed the images evaluating morphologic features and subjectively scoring Gd-EOB uptake (25-50%, 50-75% and 75-100%) for each lesion. Quantitative lesion-to-liver enhancement was measured in arterial, portal venous (PV), transitional and HBP. Additionally, multivariate regression analyses were performed.ResultsSubjective scoring of intralesional Gd-EOB uptake showed the highest discriminatory accuracies (AUC: 0.848 (R#1); 0.920 (R#2)-p<0.001) with significantly higher uptake scores assigned to FNHs (Cut-off: 75%-100%). Typical lobulation and presence of a central scar in FNH achieved an accuracy of 0.750 or higher in at least one reader (lobulation-AUC: 0.809 (R#1); 0.736 (R#2); central scar-AUC: 0.595 (R#1); 0.784 (R#2)). The multivariate regression emphasized the discriminatory power of the Gd-EOB scoring (p=0.001/OR:22.15 (R#1) and p<0.001/OR:99.12 (R#2). The lesion-to-liver ratio differed significantly between FNH and HCA in the PV phase and HBP (PV: 132.9 (FNH) and 110.2 (HCA), p=0.048 and HBP: 110.3 (FNH) and 39.2 (HCA), p<0.001)), while the difference was not significant in arterial and transitional contrast phases (p>0.05).ConclusionEven in HBP-enhancing HCA, characterization of Gd-EOB uptake was found to provide the strongest discriminatory power in differentiating HCA from FNH. Furthermore, a lobulated appearance and a central scar are more frequently seen in FNH than in HCA.
引用
收藏
页数:11
相关论文
共 32 条
  • [1] Inflammatory Hepatocellular Adenomas Can Mimic Focal Nodular Hyperplasia on Gadoxetic Acid-Enhanced MRI
    Agarwal, Sheela
    Fuentes-Orrego, Jorge M.
    Arnason, Thomas
    Misdraji, Joseph
    Jhaveri, Kartik S.
    Harisinghani, Mukesh
    Hahn, Peter F.
    [J]. AMERICAN JOURNAL OF ROENTGENOLOGY, 2014, 203 (04) : W408 - W414
  • [2] Hepatocellular adenomas: is there additional value in using Gd-EOB-enhanced MRI for subtype differentiation?
    Auer, Timo Alexander
    Fehrenbach, Uli
    Grieser, Christian
    Penzkofer, Tobias
    Geisel, Dominik
    Schmelzle, Moritz
    Mueller, Tobias
    Blaeker, Hendrik
    Seehofer, Daniel
    Denecke, Timm
    [J]. EUROPEAN RADIOLOGY, 2020, 30 (06) : 3497 - 3506
  • [3] Barthelmes Ludger, 2005, HPB (Oxford), V7, P186, DOI 10.1080/13651820510028954
  • [4] Risk factors for bleeding in hepatocellular adenoma
    Bieze, M.
    Phoa, S. S. K. S.
    Verheij, J.
    van Lienden, K. P.
    van Gulik, T. M.
    [J]. BRITISH JOURNAL OF SURGERY, 2014, 101 (07) : 847 - 855
  • [5] Hepatocellular adenoma: what is new in 2008
    Bioulac-Sage, Paulette
    Laumonier, Herve
    Laurent, Christophe
    Zucman-Rossi, Jessica
    Balabaud, Charles
    [J]. HEPATOLOGY INTERNATIONAL, 2008, 2 (03) : 316 - 321
  • [6] Genotype phenotype classification of hepatocellular adenoma
    Bioulac-Sage, Paulette
    Blanc, Lean Frederic
    Rebouissou, Sandra
    Balabaud, Charles
    Zucman-Rossi, Jessica
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2007, 13 (19) : 2649 - 2654
  • [7] Hepatocellular Adenoma Management and Phenotypic Classification: the Bordeaux Experience
    Bioulac-Sage, Paulette
    Laumonier, Herve
    Couchy, Gabrielle
    Le Bail, Brigitte
    Cunha, Antonio Sa
    Rullier, Anne
    Laurent, Christophe
    Blanc, Jean-Frederic
    Cubel, Gaelle
    Trillaud, Herve
    Zucman-Rossi, Jessica
    Balabaud, Charles
    Saric, Jean
    [J]. HEPATOLOGY, 2009, 50 (02) : 481 - 489
  • [8] EASL Clinical Practice Guidelines on the management of benign liver tumours
    Colombo, Massimo
    Forner, Alejandro
    Ijzermans, Jan
    Paradis, Valerie
    Reeves, Helen
    Vilgrain, Valerie
    Zucman-Rossi, Jessica
    [J]. JOURNAL OF HEPATOLOGY, 2016, 65 (02) : 386 - 398
  • [9] Appearance of hepatocellular adenomas on gadoxetic acid-enhanced MRI
    Denecke, Timm
    Steffen, Ingo G.
    Agarwal, Sheela
    Seehofer, Daniel
    Kroencke, Thomas
    Haenninen, Enrique Lopez
    Kramme, Incken-Birthe
    Neuhaus, Peter
    Saini, Sanjay
    Hamm, Bernd
    Grieser, Christian
    [J]. EUROPEAN RADIOLOGY, 2012, 22 (08) : 1769 - 1775
  • [10] A Single-Center Surgical Experience of 122 Patients With Single and Multiple Hepatocellular Adenomas
    Dokmak, Safi
    Paradis, Valerie
    Vilgrain, Valerie
    Sauvanet, Alain
    Farges, Olivier
    Valla, Dominique
    Bedossa, Pierre
    Belghiti, Jacques
    [J]. GASTROENTEROLOGY, 2009, 137 (05) : 1698 - 1705